A glassy carbon electrode (GC) immobilized with chitosan (CHI)@reduced graphene (rGO)-polyaniline (PAni)/ferritin (Frt)/glucose oxidase (GOx) bioelectrode was prepared. The prepared electrode was characterized by using cyclic voltammetry (CV), linear sweep voltammetry (LSV) and electrochemical impedance spectroscopy (EIS) techniques. The morphological characterization was made by scanning electron microsopy (SEM) and Fourier transform infrared (FTIR) spectroscopy. This bioelectrode provided a stable current response of 3.5 ± 0.02 mAcm−2 in 20 mM glucose. The coverage of enzyme on 0.07 cm2 area of electrode modified with CHI@rGO-PAni/Frt was calculated to be 3.80 × 10−8 mol cm−2.

No abstract

No abstract

No abstract

The proposed work intended to make an intellectual contribution to the domain of green nanotechnology which emphasizes the chemical synthesis of a conducting nanocomposite based on the incorporation of gold nanoparticles (Au) into the redox matrix of polyindole (PIn) along with the subsequent improvement in the overall properties of the composite by the addition of sulfonated graphene oxide (SGO). The bioanode was developed by the deposition of the PIn-Au-SGO nanocomposite with subsequent immobilization of ferritin (Frt) and glucose oxidase (GOx) on the glassy carbon electrode (GC). The successful application of the PIn-Au-SGO nanocomposite toward the development of a ferritin-mediated glucose biofuel cell anode was studied by the electrochemical characterization of the constructed bioanode (GC-PIn-Au-SGO/Frt/GOx) for the bioelectrocatalytic oxidation of glucose. The maximum current density obtained by the modified bioanode was found to be 17.8 mA cm−2 at the limiting glucose concentration of 50 mM in 0.1 M K4Fe(CN)6 at a scan rate of 100 mVs−1. The lifetime of the concerned bioelectrode when stored at 4 °C was estimated to be 53 days approximately. The appreciable results of the structural and electrochemical characterization of the PIn-Au-SGO based bioelectrode reveal its potential applications exclusively in implantable medical devices.